Literature DB >> 11070112

Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors.

R Rey1, J C Sabourin, M Venara, W Q Long, F Jaubert, W P Zeller, P Duvillard, H Chemes, J M Bidart.   

Abstract

Sex cord stromal tumors are gonadal neoplasms containing Sertoli, granulosa, Leydig, or thecal cells, which originate from cells derived from either the sex cords (Sertoli and granulosa cell tumors) or the specific mesenchymal stroma (Leydig and thecal cell tumors) of the embryonic gonad. Only granulosa and Sertoli cells produce anti-Müllerian hormone (AMH). Our purpose was to investigate whether AMH can be used as a specific marker of human granulosa or Sertoli cell origin in gonadal tumors, to distinguish them from other primary or metastatic neoplasms, using immunohistochemistry. We studied 7 juvenile and 6 adult-type granulosa cell tumors of ovarian localization and 3 extraovarian metastases, 20 other ovarian tumors, 6 testicular Sertoli cell tumors, 2 gonadoblastomas, and 13 extragonadal tumors. Granulosa cell tumors, both juvenile- and adult-type of either ovarian or metastatic localization, showed an heterogeneous pattern of AMH immunoreactivity: Areas containing intensely or weakly AMH-positive cells were intermingled with AMH-negative areas. Although in most cases AMH-positive areas represented a minor proportion of tumor cells, we found a positive reaction in all the cases examined. In testes, although normal prepubertal Sertoli cells were intensely positive, testicular Sertoli cell tumors showed large areas of negative reaction, with few positive cells scattered throughout the tumor. AMH was also reactive in most of the cells of sex-cord origin in gonadoblastomas. No AMH immunoreaction was observed in other gonadal and extragonadal tumors. We conclude that AMH expression is conserved in only a small proportion of tumor cells of granulosa or Sertoli cell origin; however, a positive reaction in a few cells helps to distinguish between granulosa or Sertoli cell tumors or gonadoblastomas and other gonadal tumors of different origin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070112     DOI: 10.1053/hupa.2000.18498

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  25 in total

Review 1.  Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.

Authors:  Vitaly A Kushnir; David B Seifer; David H Barad; Aritro Sen; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2017-06-22       Impact factor: 3.412

2.  Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology.

Authors:  Henry L Chang; Nima Pahlavan; Elkan F Halpern; David T MacLaughlin
Journal:  Gynecol Oncol       Date:  2009-04-08       Impact factor: 5.482

3.  The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand.

Authors:  Imed Salhi; Sylvie Cambon-Roques; Isabelle Lamarre; Daniel Laune; Franck Molina; Martine Pugnière; Didier Pourquier; Marian Gutowski; Jean-Yves Picard; Françoise Xavier; André Pèlegrin; Isabelle Navarro-Teulon
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

4.  Smad1-Smad5 ovarian conditional knockout mice develop a disease profile similar to the juvenile form of human granulosa cell tumors.

Authors:  Brooke S Middlebrook; Karen Eldin; Xiaohui Li; Sujatha Shivasankaran; Stephanie A Pangas
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

5.  Comparability of antimüllerian hormone levels among commercially available immunoassays.

Authors:  H Irene Su; Mary D Sammel; Michael V Homer; Kim Bui; Carolyn Haunschild; Frank Z Stanczyk
Journal:  Fertil Steril       Date:  2014-04-14       Impact factor: 7.329

6.  Immunophenotyping of Rabbit Testicular Germ and Sertoli Cells Across Maturational Stages.

Authors:  B Banco; G Grilli; C Giudice; A Tomas Marques; S Cotti Cometti; G Visigalli; V Grieco
Journal:  J Histochem Cytochem       Date:  2016-09-30       Impact factor: 2.479

Review 7.  The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.

Authors:  Jure Bedenk; Eda Vrtačnik-Bokal; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2019-11-21       Impact factor: 3.412

8.  [Immunohistochemical sex cord markers. Description and use in the differential diagnosis of ovarian tumors].

Authors:  F Kommoss; D Schmidt
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

9.  Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?

Authors:  Tito Silvio Patrelli; Salvatore Gizzo; Nicoletta Sianesi; Luca Levati; Antonio Pezzuto; Bruno Ferrari; Alberto Bacchi Modena
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

10.  Prediction of reproductive outcomes according to different serum anti-Müllerian hormone levels in females undergoing intracystoplasmic sperm injection.

Authors:  Santiago Brugo Olmedo; Sabrina De Vincentiis; Evelyn De Martino; Patricia Bedecarrás; Ana María Blanco; Analía Freire; Mariano G Buffone; Rodolfo A Rey
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.